Popular Articles
Stretch Mark

Mexican, Chilean Presidents Appeal For Developing Countries Access To H1N1 Vaccine
Mexican President Felipe Calderon and Chilean President Michelle Bachelet on Thursday emphasized the importance of developing countries having access to a vaccine that offers protection against the H1N1 (swine flu), "that has killed over 200 people and infected tens of thousands worldwide," AFP/MSN Philippine News reports.
generic viagra online
ACMG Joins Lawsuit Challenging Patents On Breast Cancer Genes
The American College of Medical Genetics (ACMG) has joined the Association for Molecular Pathology, the College of American Pathologists, and the American Society for Clinical Pathology in a lawsuit filed today charging that patents on the human genes associated with breast and ovarian cancer interfere with diagnostic testing, stifle research and limit women"s options regarding their health care. The lawsuit challenges patents on the BRCA1 and BRCA2 genes, which are responsible for most cases of hereditary breast and ovarian cancers. Because these genes are "products of nature," the ACMG believes that granting patents on them is illegal.
News of the day
New Data Supports Significant Economic And Clinical Value Of MENOPUR(R) In IVF
New data from an economic analysis presented today at this year"s European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in vitro fertilisation (IVF) treatment MENOPUR (highly-purified human menopausal gonatropin or HP-hMG) offered considerable cost-savings over recombinant follicle stimulating hormone (rFSH).1 The cost-effectiveness of HP-hMG compared with rFSH suggested by this data could make it a more attractive choice for use in infertility treatment within a fixed healthcare budget.
Cardiovascular

Yale Scientists Develop 'Gas Gauge' To Prevent Pregnancy Loss

To combat the many fetal deaths that occur annually because the placenta is too small, researchers at Yale School of Medicine have developed a method to measure the volume of the placenta, which provides nourishment to the fetus. Limits in current technology keep doctors from being able to monitor the growth of the placenta, which, like the gas tank of a car, is the of fuel for the fetus. The placenta can be so small that the fetus literally runs out of food and oxygen and dies, according to lead author Harvey J. Kliman, M.D., a research scientist in the Department of Obstetrics, Gynecology and Reproductive Sciences. He and his colleagues published the results of their findings in the August 3 issue of the American Journal of Perinatology. Fetal death, or intrauterine fetal demise (IUFD), affects 30,000 women each year in the United States. Until now, there has been no easy way to determine how much "gas" is left in the placenta"s tank. Kliman decided to study this issue after noting that many late-term pregnancy losses were associated with very small placentas. He theorized that in much the same way that an obstetrician uses ultrasounds to follow the growth of the fetus, or a pediatrician weighs and measures children to ensure they are growing normally, the growth of the fetus" placenta could be monitored. When Kliman asked perinatologists (maternal fetal medicine specialists) why they did not look at the placenta when performing routine ultrasounds, the answer was always the same: The placenta is a curved structure and is too difficult to measure. If they had to measure the placental volume they would need a very expensive machine, specialized training and more time. With the help of his father, Merwin Kliman, a mathematician and electrical engineer, Kliman developed an equation that used the maximal width, height and thickness of the placenta. Kliman and his team at Yale then validated the method by comparing the volume predicted by the Estimated Placenta Volume (EPV) equation taken just before delivery to the actual weight of the placenta at the time of delivery. "In this study, we showed that the equation predicted the actual placental weight with an accuracy of up to 89 percent," said Kliman. "The method works best during the second and early third trimesters, just when routine ultrasound screening is done on many women in the U.S." In addition to validating the equation, the team is also collecting EPV data from centers around the world to create the normative curves that doctors can use to determine if the placenta is normal, too small or even too big. "I hope that the EPV test becomes routine for pregnant women," said Kliman. Other authors on the study include Humberto Azpurua, M.D., Edmund F. Funai, M.D., Luisa M. Coraluzzi, Leo F. Doherty, M.D., Isaac E. Sasson, M.D., and Merwin Kliman. Citation: American Journal of Perinatology (August 3, 2009) Yale University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):